Medical Marijuana, Inc. Subsidiary Kannaway® Attracts Direct Selling Leadership

SAN DIEGO, Oct. 31, 2018 — Medical Marijuana, Inc. (OTC:MJNA), ), the first-ever publicly traded cannabis company in the United States, announced today that its subsidiary Kannaway®, the first direct selling company to offer cannabidiol (CBD) hemp botanical products, has attracted new leadership to its Brand Ambassador base. The company is proud to announce that Gordon Oswald and Glade Poulsen have joined the company, both bringing their vast, decade-spanning successes in the direct selling industry to the team.

Both of these new Kannaway® Brand Ambassadors will be working with Randy Schroeder. He has been a leader with Kannaway® for several years and has worked his way to earn Crown Ambassador Elite rank. He has been recognized numerous times for his dedication to educating others about Kannaway’s® CBD hemp oil products.

“There is no such thing as independent success in Kannaway. We achieve the most when we put our heads together and use our collaborative knowledge to find creative solutions,” Schroeder said. “Gordon and Glade have a combined 50 years of experience in the direct selling industry and their efforts have helped generate over three billion dollars in product sales and distribution for some of the finest companies in the direct selling industry.”

Glade Poulsen previously worked with Schroeder in building almost the entirety of the Asian business, including Hong Kong, Taiwan, Korea, Japan and later China, for another direct selling company. Together, they were able to achieve over $100 million annually in sales. Poulsen also became the prime driver of the European business for another multi-national direct selling company. He has a keen talent for bridging Western and Eastern cultures with time-tested business practices and relationship skills.

“It’s an honor to work alongside some of the greatest in the direct selling industry and open up this emerging wellness alternative business to new markets around the world,” Poulsen said. “I look forward to bringing these beneficial products to millions of people and help increase access to CBD worldwide.”

Gordon Oswald has more than 20 years of experience in both B2B and B2C sales as a leader, has a strong history of exceeding sales targets for services and products, and is responsible for generating over $1 billion in revenue during that time. He is also a notable leader in the direct selling industry, leading the domestic and international successes of two prominent personal care product companies.

“I’ve tackled projects big and small all around the world and this opportunity with Kannaway is especially exciting because of the developing industry that hemp oil products will offer consumers for generations to come,” Oswald said. “The Eastern world already understands the benefits of holistic, natural wellness so our job will be a matter of positioning and understanding the needs of their people, who just like us, want to feel and look their best every day.”

Kannaway® CEO Blake Schroeder said, “These gentlemen will represent our company well and we could not be more excited about the future of Kannaway. We are confident that their leadership will pave the path for the company’s continued growth and success.”

For more information about Kannaway®, please visit the company website here.

About Kannaway®

Kannaway® is a network sales and marketing company specializing in the sales and marketing of hemp-based botanical products. Kannaway® currently hosts weekly online sales meetings and conferences across the United States, offering unique insight and opportunity to sales professionals who are desirous of becoming successful leaders in the sale and marketing of hemp-based botanical products.

About Medical Marijuana, Inc.

We are a company of firsts®. Our mission is to be the premier cannabis and hemp industry innovators, leveraging our team of professionals to source, evaluate and purchase value-added companies and products, while allowing them to keep their integrity and entrepreneurial spirit. We strive to create awareness within our industry, develop environmentally-friendly, economically sustainable businesses, while increasing shareholder value. For details on Medical Marijuana, Inc.’s portfolio and investment companies, visit

To see Medical Marijuana, Inc.’s corporate video, click here.

Shareholders and consumers are also encouraged to buy CBD oil and other products at Medical Marijuana, Inc.’s shop.


This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of Medical Marijuana, Inc. to be materially different from the statements made herein.


These statements have not been evaluated by the FDA and are not intended to diagnose, treat or cure any disease.


Medical Marijuana, Inc. does not sell or distribute any products that are in violation of the United States Controlled Substances Act (US.CSA). These companies do grow, sell, and distribute hemp-based products and are involved with the federally legal distribution of medical marijuana-based products within certain international markets. Cannabidiol is a natural constituent of hemp oil.


Public Relations Contact:

Andrew Hard

Chief Executive Officer

CMW Media


[email protected]